found that the detection rate of P. gingivalis in patients with NAFLD was significantly higher than that in the control group, and periodontal treatments decreased the serum AST and ALT levels of NAFLD patients (Yoneda et al., 2012). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.